Comparison of Different Doses of Vitamin D Supplementation on Glycated Haemoglobin and Blood Glucose Parameters With Type II Diabetes Mellitus Having Vitamin d Deficiency
NCT ID: NCT07321223
Last Updated: 2026-01-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
108 participants
INTERVENTIONAL
2024-08-22
2026-02-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Vitamin D Supplementation on Hemoglobin A1c in Patients With Uncontrolled Type 2 Diabetes Mellitus
NCT00985361
Effect of Vitamin D Supplementation on Hemoglobin A1c
NCT01354262
Effects of Vitamin D and Calcium on Hyperglycemia and Dyslipidemia in Patients Gestational Diabetes
NCT06896669
The Effect of Vitamin D Supplementation in Type 2 Diabetes
NCT01854463
The Impact of Vitamin D Supplementation on Pregnant Women With the Risk of GDM
NCT06139133
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment Group-1
Treatment vitamin D capsules with different dosage (50,000IU) once a week for 90days
Vitamin D
Vitamin D supplement capsules (50,000 IU, 200000 IU)
Placebo
Only Metformin and Balance Diet
No interventions assigned to this group
Treatment Group 2
Treatment vitamin D capsules with different dosage (200000IU) once a week for 90days
Vitamin D
Vitamin D supplement capsules (50,000 IU, 200000 IU)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vitamin D
Vitamin D supplement capsules (50,000 IU, 200000 IU)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Exclusion Criteria
* Renal, hepatic, endocrinological disorders or malignancies on basis of history
* Serum calcium levels \> 10.5mg/dl
* Use of insulin or any change in dosage of current hypoglycemic medications during last 3 months
* Intake of vitamin D, calcium or omega 3 supplements within the past 3 months
40 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Lahore
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
PAF Hospital
Islamabad, , Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB-UOL-FAHS/880/2021
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.